Lidoderm^® is the first FDA-approved therapy indicated to relieve the pain of postherpetic neuralgia.

Frova^® is indicated for the acute treatment of migraine with or without aura in adults. Its unique pharmacological profile and low mean recurrence rate would suggest that Frova^® is an excellent option for patients who experience Menstrually Related Migraines (MRM) and other migraines that last a long time and have high rates of recurrence.

Percocet^® 2.5/325 tablets treat moderate to moderately severe pain with the lowest oxycodone dose available.